Frick, L W <br/><br/>
Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Nov 1993 
 - 2285-92 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.37.11.2285  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antiviral Agents--metabolism<br/>Biological Availability<br/>Biotransformation<br/>Brain--metabolism<br/>Chromatography, High Pressure Liquid<br/>Emtricitabine--analogs & derivatives<br/>HIV-1--drug effects<br/>Half-Life<br/>Hepatitis B virus--drug effects<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Rats<br/>Rats, Sprague-Dawley<br/>Spectrophotometry, Ultraviolet<br/>Tissue Distribution<br/>Zalcitabine--analogs & derivatives